Asia-Pacific Professional Acne Medication Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE

           6.1      OVERVIEW

           6.2      INFLAMMATORY ACNE

                         6.2.1      INFLAMMATORY ACNE MARKET, BY COUNTRY

           6.3      NON-INFLAMMATORY ACNE

                         6.3.1      NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

7      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION

           7.1      OVERVIEW

           7.2      TOPICAL MEDICATIONS

                         7.2.1      TOPICAL MEDICATIONS MARKET, BY COUNTRY

           7.3      ORAL MEDICATIONS

                         7.3.1      ORAL MEDICATIONS MARKET, BY COUNTRY

8      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS

           8.1      OVERVIEW

           8.2      RETINOIDS

                         8.2.1      RETINOIDS MARKET, BY COUNTRY

           8.3      ANTIBIOTICS

                         8.3.1      ANTIBIOTICS MARKET, BY COUNTRY

           8.4      SALICYLIC ACID

                         8.4.1      SALICYLIC ACID MARKET, BY COUNTRY

           8.5      BENZOYL PEROXIDE

                         8.5.1      BENZOYL PEROXIDE MARKET, BY COUNTRY

           8.6      OTHERS

                         8.6.1      OTHERS MARKET, BY COUNTRY

9      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL

           9.1      OVERVIEW

           9.2      MED SPA

                         9.2.1      MED SPA MARKET, BY COUNTRY

           9.3      AESTHETICIAN

                         9.3.1      AESTHETICIAN MARKET, BY COUNTRY

           9.4      DERMATOLOGIST

                         9.4.1      DERMATOLOGIST MARKET, BY COUNTRY

           9.5      OTHER PROFESSIONAL CHANNELS

                         9.5.1      OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

10   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

           10.1   OVERVIEW

           10.2   AUSTRALIA

                         10.2.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.2.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.2.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.2.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.3   CHINA

                         10.3.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.3.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.3.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.3.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.4   INDIA

                         10.4.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.4.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.4.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.4.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.5   JAPAN

                         10.5.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.5.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.5.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.5.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.6   SOUTH KOREA

                         10.6.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.6.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.6.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.6.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.7   TAIWAN

                         10.7.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.7.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.7.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.7.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.8   VIETNAM

                         10.8.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.8.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.8.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.8.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.9   REST OF ASIA-PACIFIC

                         10.9.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.9.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.9.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.9.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11   COMPANY PROFILES

           11.1   BAYER AG

                         11.1.1   COMPANY OVERVIEW

                         11.1.2   COMPANY SNAPSHOT

                         11.1.3   OPERATING BUSINESS SEGMENTS

                         11.1.4   PRODUCT PORTFOLIO

                         11.1.5   BUSINESS PERFORMANCE

                         11.1.6   BUSINESS SEGMENTS

                         11.1.7   GEOGRAPHIC SEGMENTS

                         11.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.1.9   PRIMARY MARKET COMPETITORS

           11.2   NESTLE S.A.

                         11.2.1   COMPANY OVERVIEW

                         11.2.2   COMPANY SNAPSHOT

                         11.2.3   OPERATING BUSINESS SEGMENTS

                         11.2.4   PRODUCT PORTFOLIO

                         11.2.5   BUSINESS PERFORMANCE

                         11.2.6   BUSINESS SEGMENTS

                         11.2.7   GEOGRAPHIC SEGMENTS

                         11.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.2.9   PRIMARY MARKET COMPETITORS

           11.3   PFIZER INC.

                         11.3.1   COMPANY OVERVIEW

                         11.3.2   COMPANY SNAPSHOT

                         11.3.3   OPERATING BUSINESS SEGMENTS

                         11.3.4   PRODUCT PORTFOLIO

                         11.3.5   BUSINESS PERFORMANCE

                         11.3.6   BUSINESS SEGMENTS

                         11.3.7   GEOGRAPHIC SEGMENTS

                         11.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.3.9   PRIMARY MARKET COMPETITORS

           11.4   JOHNSON AND JOHNSON

                         11.4.1   COMPANY OVERVIEW

                         11.4.2   COMPANY SNAPSHOT

                         11.4.3   OPERATING BUSINESS SEGMENTS

                         11.4.4   PRODUCT PORTFOLIO

                         11.4.5   BUSINESS PERFORMANCE

                         11.4.6   BUSINESS SEGMENTS

                         11.4.7   GEOGRAPHIC SEGMENTS

                         11.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.4.9   PRIMARY MARKET COMPETITORS

           11.5   ROCHE HOLDING AG

                         11.5.1   COMPANY OVERVIEW

                         11.5.2   COMPANY SNAPSHOT

                         11.5.3   OPERATING BUSINESS SEGMENTS

                         11.5.4   PRODUCT PORTFOLIO

                         11.5.5   BUSINESS PERFORMANCE

                         11.5.6   BUSINESS SEGMENTS

                         11.5.7   GEOGRAPHIC SEGMENTS

                         11.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.5.9   PRIMARY MARKET COMPETITORS

           11.6   GLAXOSMITHKLINE PLC

                         11.6.1   COMPANY OVERVIEW

                         11.6.2   COMPANY SNAPSHOT

                         11.6.3   OPERATING BUSINESS SEGMENTS

                         11.6.4   PRODUCT PORTFOLIO

                         11.6.5   BUSINESS PERFORMANCE

                         11.6.6   BUSINESS SEGMENTS

                         11.6.7   GEOGRAPHIC SEGMENTS

                         11.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.6.9   PRIMARY MARKET COMPETITORS

           11.7   GALDERMA S.A.

                         11.7.1   COMPANY OVERVIEW

                         11.7.2   COMPANY SNAPSHOT

                         11.7.3   OPERATING BUSINESS SEGMENTS

                         11.7.4   PRODUCT PORTFOLIO

                         11.7.5   BUSINESS PERFORMANCE

                         11.7.6   BUSINESS SEGMENTS

                         11.7.7   GEOGRAPHIC SEGMENTS

                         11.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.7.9   PRIMARY MARKET COMPETITORS

           11.8   ALLERGAN PLC

                         11.8.1   COMPANY OVERVIEW

                         11.8.2   COMPANY SNAPSHOT

                         11.8.3   OPERATING BUSINESS SEGMENTS

                         11.8.4   PRODUCT PORTFOLIO

                         11.8.5   BUSINESS PERFORMANCE

                         11.8.6   BUSINESS SEGMENTS

                         11.8.7   GEOGRAPHIC SEGMENTS

                         11.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.8.9   PRIMARY MARKET COMPETITORS

           11.9   STIEFEL LABORATORIES INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   COMPANY SNAPSHOT

                         11.9.3   OPERATING BUSINESS SEGMENTS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   BUSINESS PERFORMANCE

                         11.9.6   BUSINESS SEGMENTS

                         11.9.7   GEOGRAPHIC SEGMENTS

                         11.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.9.9   PRIMARY MARKET COMPETITORS

           11.10   BAUSCH HEALTH COMPANIES INC.

                         11.10.1   COMPANY OVERVIEW

                         11.10.2   COMPANY SNAPSHOT

                         11.10.3   OPERATING BUSINESS SEGMENTS

                         11.10.4   PRODUCT PORTFOLIO

                         11.10.5   BUSINESS PERFORMANCE

                         11.10.6   BUSINESS SEGMENTS

                         11.10.7   GEOGRAPHIC SEGMENTS

                         11.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 4. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 6. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 7. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 8. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 9. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 10. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 12. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 13. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 14. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 15. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 16. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 18. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 19. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 20. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 21. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 22. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 23. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 24. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 25. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 26. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 27. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 28. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 29. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 30. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 31. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 32. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 33. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 34. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 35. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 36. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 37. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 38. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 39. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 40. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 41. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 42. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 43. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 44. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 45. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 46. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 47. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 48. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 49. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 50. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 51. BAYER AG: COMPANY SNAPSHOT

TABLE 52. BAYER AG: OPERATING BUSINESS SEGMENTS

TABLE 53. BAYER AG: PRODUCT PORTFOLIO

TABLE 54. BAYER AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 55. BAYER AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 56. BAYER AG: KEY STRATERGY

TABLE 57. NESTLE S.A.: COMPANY SNAPSHOT

TABLE 58. NESTLE S.A.: OPERATING BUSINESS SEGMENTS

TABLE 59. NESTLE S.A.: PRODUCT PORTFOLIO

TABLE 60. NESTLE S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 61. NESTLE S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 62. NESTLE S.A.: KEY STRATERGY

TABLE 63. PFIZER INC.: COMPANY SNAPSHOT

TABLE 64. PFIZER INC.: OPERATING BUSINESS SEGMENTS

TABLE 65. PFIZER INC.: PRODUCT PORTFOLIO

TABLE 66. PFIZER INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 67. PFIZER INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 68. PFIZER INC.: KEY STRATERGY

TABLE 69. JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 70. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS

TABLE 71. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 72. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 73. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 74. JOHNSON AND JOHNSON: KEY STRATERGY

TABLE 75. ROCHE HOLDING AG: COMPANY SNAPSHOT

TABLE 76. ROCHE HOLDING AG: OPERATING BUSINESS SEGMENTS

TABLE 77. ROCHE HOLDING AG: PRODUCT PORTFOLIO

TABLE 78. ROCHE HOLDING AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 79. ROCHE HOLDING AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 80. ROCHE HOLDING AG: KEY STRATERGY

TABLE 81. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT

TABLE 82. GLAXOSMITHKLINE PLC: OPERATING BUSINESS SEGMENTS

TABLE 83. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO

TABLE 84. GLAXOSMITHKLINE PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 85. GLAXOSMITHKLINE PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 86. GLAXOSMITHKLINE PLC: KEY STRATERGY

TABLE 87. GALDERMA S.A.: COMPANY SNAPSHOT

TABLE 88. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS

TABLE 89. GALDERMA S.A.: PRODUCT PORTFOLIO

TABLE 90. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 91. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 92. GALDERMA S.A.: KEY STRATERGY

TABLE 93. ALLERGAN PLC: COMPANY SNAPSHOT

TABLE 94. ALLERGAN PLC: OPERATING BUSINESS SEGMENTS

TABLE 95. ALLERGAN PLC: PRODUCT PORTFOLIO

TABLE 96. ALLERGAN PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 97. ALLERGAN PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 98. ALLERGAN PLC: KEY STRATERGY

TABLE 99. STIEFEL LABORATORIES INC.: COMPANY SNAPSHOT

TABLE 100. STIEFEL LABORATORIES INC.: OPERATING BUSINESS SEGMENTS

TABLE 101. STIEFEL LABORATORIES INC.: PRODUCT PORTFOLIO

TABLE 102. STIEFEL LABORATORIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 103. STIEFEL LABORATORIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 104. STIEFEL LABORATORIES INC.: KEY STRATERGY

TABLE 105. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT

TABLE 106. BAUSCH HEALTH COMPANIES INC.: OPERATING BUSINESS SEGMENTS

TABLE 107. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO

TABLE 108. BAUSCH HEALTH COMPANIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 109. BAUSCH HEALTH COMPANIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 110. BAUSCH HEALTH COMPANIES INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

FIGURE 7. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

FIGURE 13. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 15. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 18. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

FIGURE 19. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 20. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 21. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 23. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 24. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 25. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 26. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 27. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 28. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 29. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 30. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 31. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 32. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 33. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 34. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 35. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 36. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 37. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 38. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 39. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 40. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 41. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 42. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 43. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 44. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 45. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 46. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 47. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 48. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 49. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 50. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 51. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 52. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 53. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 54. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 55. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 56. BAYER AG: NET SALES, (2021-2023)

FIGURE 57. BAYER AG: PRIMARY MARKET COMPETITORS

FIGURE 58. NESTLE S.A.: NET SALES, (2021-2023)

FIGURE 59. NESTLE S.A.: PRIMARY MARKET COMPETITORS

FIGURE 60. PFIZER INC.: NET SALES, (2021-2023)

FIGURE 61. PFIZER INC.: PRIMARY MARKET COMPETITORS

FIGURE 62. JOHNSON AND JOHNSON: NET SALES, (2021-2023)

FIGURE 63. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS

FIGURE 64. ROCHE HOLDING AG: NET SALES, (2021-2023)

FIGURE 65. ROCHE HOLDING AG: PRIMARY MARKET COMPETITORS

FIGURE 66. GLAXOSMITHKLINE PLC: NET SALES, (2021-2023)

FIGURE 67. GLAXOSMITHKLINE PLC: PRIMARY MARKET COMPETITORS

FIGURE 68. GALDERMA S.A.: NET SALES, (2021-2023)

FIGURE 69. GALDERMA S.A.: PRIMARY MARKET COMPETITORS

FIGURE 70. ALLERGAN PLC: NET SALES, (2021-2023)

FIGURE 71. ALLERGAN PLC: PRIMARY MARKET COMPETITORS

FIGURE 72. STIEFEL LABORATORIES INC.: NET SALES, (2021-2023)

FIGURE 73. STIEFEL LABORATORIES INC.: PRIMARY MARKET COMPETITORS

FIGURE 74. BAUSCH HEALTH COMPANIES INC.: NET SALES, (2021-2023)

FIGURE 75. BAUSCH HEALTH COMPANIES INC.: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.